Articles publiés en 2012

Lenoir-Wijnkoop I, Nuijten MJ, Gutiérrez-Ibarluzea I, Hutton J, Poley MJ, Segal L, Bresson JL, van Ganse E, Jones P, Moreno L, Salminen S, Dubois D. Workshop Report: concepts and methods in the economics of nutrition–gateways to better economic evaluation of nutrition interventions. Br J Nutr. 2012 Nov 14;108(9):1714-20. doi: 10.1017/S0007114512003704. PMID: 22947201
Boussageon R, Laforest L, Van Ganse E [Are fixed combinations of inhaled corticosteroids and long-acting β2-agonists really harmless in asthmatics?]. Rev Mal Respir. 2012 Nov;29(9):1169-70; author reply 1170-1. doi: 10.1016/j.rmr.2012.09.009. French. Erratum in: Rev Mal Respir. 2013 Mar;30(3):248. PMID: 23200594.
Désaméricq G, Van Ganse E, Schwalm MS, Bourke A, Moulin P. Severe hypertriglyceridaemia in patients treated with lipid-modifying agents. Diabetes Metab. 2012 Jun;38(3):277-9. doi: 10.1016/j.diabet.2012.02.009. PMID: 22498019.
Van Ganse E, Letrilliart L, Borne H, Morand F, Robain M, Siegrist CA. Health problems most commonly diagnosed among young female patients during visits to general practitioners and gynecologists in France before the initiation of the human papillomavirus vaccination program. Pharmacoepidemiol Drug Saf. 2012 Mar;21(3):261-8. doi: 10.1002/pds.2243. PMID: 22052698.
Marant C, Longin J, Gauchoux R, Arnould B, Spizak C, Marrel A, Patrick DL, Van Ganse E. Long-term treatment acceptance: what is it, and how can it be assessed? Patient. 2012;5(4):239-49. doi: 10.2165/11631340-000000000-00000. PMID: 23116323.
Laforest L, Ambegaonkar BM, Souchet T, Sazonov V, Van Ganse E. Mixed dyslipidemias in primary care patients in France. Vasc Health Risk Manag. 2012;8:247-54. doi: 10.2147/VHRM.S27668. PMID: 22566746.